Nothing Special   »   [go: up one dir, main page]

CO4960656A1 - Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)1h- indol - Google Patents

Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)1h- indol

Info

Publication number
CO4960656A1
CO4960656A1 CO98046788A CO98046788A CO4960656A1 CO 4960656 A1 CO4960656 A1 CO 4960656A1 CO 98046788 A CO98046788 A CO 98046788A CO 98046788 A CO98046788 A CO 98046788A CO 4960656 A1 CO4960656 A1 CO 4960656A1
Authority
CO
Colombia
Prior art keywords
alkyl
hydrogen
cyano
nitrogen
trifluoromethyl
Prior art date
Application number
CO98046788A
Other languages
English (en)
Spanish (es)
Inventor
Franz Josef Fliri Anton
Mark Jerome Majchrzak
Seymour Patricia Ann
Howard Zorn Stevin
Hans Rollema
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CO4960656A1 publication Critical patent/CO4960656A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO98046788A 1997-08-15 1998-08-14 Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)1h- indol CO4960656A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5576497P 1997-08-15 1997-08-15

Publications (1)

Publication Number Publication Date
CO4960656A1 true CO4960656A1 (es) 2000-09-25

Family

ID=22000003

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98046788A CO4960656A1 (es) 1997-08-15 1998-08-14 Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)1h- indol

Country Status (30)

Country Link
EP (1) EP1003739A2 (tr)
JP (1) JP2002536291A (tr)
KR (1) KR20010022507A (tr)
CN (1) CN1265660A (tr)
AP (1) AP9801321A0 (tr)
AR (1) AR017019A1 (tr)
AU (1) AU8457298A (tr)
BG (1) BG104069A (tr)
BR (1) BR9811557A (tr)
CA (1) CA2297486C (tr)
CO (1) CO4960656A1 (tr)
DZ (1) DZ2583A1 (tr)
EA (1) EA200000023A1 (tr)
HR (1) HRP980441A2 (tr)
HU (1) HUP0003425A3 (tr)
ID (1) ID23803A (tr)
IL (1) IL133960A0 (tr)
IS (1) IS5336A (tr)
MA (1) MA24632A1 (tr)
NO (1) NO20000722L (tr)
OA (1) OA11286A (tr)
PA (1) PA8457001A1 (tr)
PE (1) PE106299A1 (tr)
PL (1) PL338947A1 (tr)
SK (1) SK1352000A3 (tr)
TN (1) TNSN98151A1 (tr)
TR (1) TR200000414T2 (tr)
UY (1) UY25144A1 (tr)
WO (1) WO1999009025A2 (tr)
ZA (1) ZA987304B (tr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9813279B1 (pt) * 1997-10-27 2010-11-16 derivado de homopiperazina, composição farmacêutica, e, uso do derivado de homopiperazina.
EP0953567A3 (en) * 1998-04-29 2003-04-02 Pfizer Products Inc. Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity
EA008627B1 (ru) * 1999-12-30 2007-06-29 Х. Лундбекк А/С Замещенные галогеном производные 4-фенил-1-пиперазинила, их применение и содержащая их фармацевтическая композиция
GB0017952D0 (en) * 2000-07-22 2000-09-13 Univ Manchester Treatment of dyskinesia
EP1177792A3 (en) 2000-07-27 2002-10-23 Pfizer Products Inc. Dopamine D4 Ligands for the treatment of novelty-seeking disorders
JP4544820B2 (ja) * 2001-03-09 2010-09-15 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 複素環化合物
RU2005106274A (ru) 2002-09-06 2005-11-10 Янссен Фармацевтика, Н.В. (Be) Гетероциклические соединения
WO2004108671A1 (en) * 2003-06-06 2004-12-16 Suven Life Sciences Limited Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
WO2005095338A1 (ja) 2004-03-30 2005-10-13 Takeda Pharmaceutical Company Limited アルコキシフェニルプロパン酸誘導体
US7618980B2 (en) 2004-07-14 2009-11-17 Bristol-Myers Squibb Company Pyrrolo(oxo)quinolines as 5HT ligands
US7572805B2 (en) 2004-07-14 2009-08-11 Bristol-Myers Squibb Company Pyrrolo(oxo)isoquinolines as 5HT ligands
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JP5431305B2 (ja) 2007-04-23 2014-03-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 高速解離性ドパミン2受容体アンタゴニストとしての4−アルコキシピリダジン誘導体
WO2008128996A1 (en) 2007-04-23 2008-10-30 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
CA2729313C (en) 2008-07-03 2016-08-30 Janssen Pharmaceutica Nv Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists
EP2307374B1 (en) 2008-07-31 2017-01-25 Janssen Pharmaceutica NV Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
US11266640B2 (en) * 2017-09-20 2022-03-08 Hangzhou Innogate Pharma Co., Ltd. Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor
JP2023523176A (ja) * 2020-04-22 2023-06-02 アニマ バイオテック インコーポレイテッド コラーゲン1翻訳阻害剤及びその使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (tr) * 1959-09-25 1900-01-01
DK0594702T3 (da) * 1991-07-03 1997-07-21 Upjohn Co Substituerede indoler som midler mod AIDS
JPH05255089A (ja) * 1991-12-18 1993-10-05 Sanwa Kagaku Kenkyusho Co Ltd 抗ウイルス剤
JPH08502958A (ja) * 1992-10-23 1996-04-02 メルク シヤープ エンド ドーム リミテツド ドーパミンレセプターサブタイプリガンド
AU6215594A (en) * 1993-03-18 1994-10-11 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
GB9305644D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
US5814644A (en) * 1993-04-15 1998-09-29 Merck Sharp & Dohme, Ltd. Indole derivatives as dopamine D4 antagonists
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
ZA968661B (en) * 1995-11-17 1998-04-14 Upjohn Co Oxazolidinone antibacterial agent with tricyclic substituents.
TW504510B (en) * 1996-05-10 2002-10-01 Janssen Pharmaceutica Nv 2,4-diaminopyrimidine derivatives

Also Published As

Publication number Publication date
EP1003739A2 (en) 2000-05-31
AP9801321A0 (en) 2000-02-14
JP2002536291A (ja) 2002-10-29
BR9811557A (pt) 2000-08-22
NO20000722D0 (no) 2000-02-14
WO1999009025A2 (en) 1999-02-25
TR200000414T2 (tr) 2000-08-21
SK1352000A3 (en) 2000-08-14
CN1265660A (zh) 2000-09-06
IS5336A (is) 2000-01-11
NO20000722L (no) 2000-02-14
OA11286A (en) 2003-10-22
IL133960A0 (en) 2001-04-30
HRP980441A2 (en) 1999-04-30
CA2297486C (en) 2005-05-03
HUP0003425A2 (hu) 2001-10-28
WO1999009025A3 (en) 1999-04-15
EA200000023A1 (ru) 2000-08-28
CA2297486A1 (en) 1999-02-25
AR017019A1 (es) 2001-08-22
MA24632A1 (fr) 1999-04-01
BG104069A (en) 2001-05-31
HUP0003425A3 (en) 2002-02-28
ID23803A (id) 2000-05-11
TNSN98151A1 (fr) 2005-03-15
PL338947A1 (en) 2000-12-04
AU8457298A (en) 1999-03-08
PE106299A1 (es) 1999-11-02
DZ2583A1 (fr) 2003-02-22
ZA987304B (en) 2000-02-14
PA8457001A1 (es) 2000-09-29
UY25144A1 (es) 2000-12-29
KR20010022507A (ko) 2001-03-15

Similar Documents

Publication Publication Date Title
CO4960656A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)1h- indol
CO4650135A1 (es) Lactamas e imidas heterociclicas de aralquilo y aralquilideno
CO4600634A1 (es) Derivados 6,5-heterobiciclicos sustituidos
ES2173846T3 (es) Compuestos de biciclocarbonil indol como agentes antiinflamatorios/analgesicos y como inhibidores de cox-2.
CO5310534A1 (es) Nuevos derivados de androstano anti-inflamatorios
CO5721002A2 (es) Derivados de acido 3-(4-benciloxifenil) propanoico
CO4970713A1 (es) Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
AR090649A2 (es) Inhibidores del virus de la hepatitis c
CO4940458A1 (es) Novedosos inhibidores de urea n-sustituida de transferasa de proteina farnesilo
CO4650033A1 (es) Derivados de lactama con actividad selectiva agonista y antagonista de receptores de serotonina 1 (5ht) y composiciones farmaceuticas que los contienen .
NI200800008A (es) Métodos para la neuroprotección
AR021534A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonano, su preparacion y su aplicacion en terapeutica
CO4900059A1 (es) 3- ureido-piridofuranos y- piridotiofenos
CO5550440A2 (es) Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona,su preparacion y su aplicacion en terapeutica
EA200300777A1 (ru) N-фенпропилциклопентил-замещенные производные глутарамида в качестве nep ингибиторов для fsad
CO5060482A1 (es) Derivados terapeuticos de biarilo
UY25986A1 (es) Complejo del inhibidor de ras-farnesiltransferasa y sulfobutiléter-7-beta-ciclodextrina o 2-hidroxipropil-beta-ciclodextrina y método.
AR065795A1 (es) Derivados de aza-piridopirimidinona,metodo de preparacion,medicamentos que los contienen y usos como agentes antitromboticos, antihiperlipidemicos y antidiabeticos,entre otros.
CO4950561A1 (es) Derivados de ergolina
EA200400748A1 (ru) Агонисты рецепторов, активируемых пероксисомным пролифератором
EA200401470A1 (ru) Производные пиперазинилацилпиперидина, их получение и их терапевтическое применение
AR024918A1 (es) Derivados de ciclobuteno, su preparacion y sus usos terapeuticos.
AR039122A1 (es) Derivados de ftalimido como inhibidores de monoamino oxidasa b
EA200200727A1 (ru) Новые производные индола
ECSP045176A (es) Derivados de 5-(piridin-3-il)-1-azabiciclo[3.2.1]octano, su preparacion y su aplicación en terapeutica